CJC-1295
GHRH analog for anti-aging and GH optimization
Overview
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates GH secretion. Available with or without DAC (Drug Affinity Complex), which extends its half-life significantly.
Mechanism of Action
Binds GHRH receptors on pituitary somatotrophs → stimulates GH release in a pulsatile manner → increases IGF-1 levels → DAC version binds albumin for extended duration.
Benefits
- Increased GH and IGF-1 levels
- Improved body composition
- Enhanced recovery
- Better sleep quality
- Anti-aging effects
Dosing Protocol
Half-Life
~30 min (no DAC) / ~8 days (with DAC)
Duration of pharmacological activity after administration.
Side Effects
- Water retention
- Tingling/numbness
- Flushing
- Headache
- Injection site reactions
Stacking Recommendations
Storage & Reconstitution
Lyophilized: -20°C. Reconstituted: 2–8°C, use within 21 days.
Research Notes
Well-studied GHRH analog. CJC-1295/DAC showed sustained GH elevation for 6–8 days per injection. Widely used in anti-aging and sports medicine research.
Medical Disclaimer
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. Peptide therapy should only be initiated under the supervision of a qualified healthcare provider. Individual results may vary. Always consult with your physician before starting any new therapy. Regulatory status varies by jurisdiction.